161 related articles for article (PubMed ID: 20728451)
1. Molecular insight into the conformational dynamics of the Elongin BC complex and its interaction with HIV-1 Vif.
Marcsisin SR; Engen JR
J Mol Biol; 2010 Oct; 402(5):892-904. PubMed ID: 20728451
[TBL] [Abstract][Full Text] [Related]
2. Insight into the HIV-1 Vif SOCS-box-ElonginBC interaction.
Lu Z; Bergeron JR; Atkinson RA; Schaller T; Veselkov DA; Oregioni A; Yang Y; Matthews SJ; Malim MH; Sanderson MR
Open Biol; 2013 Nov; 3(11):130100. PubMed ID: 24225024
[TBL] [Abstract][Full Text] [Related]
3. The SOCS-box of HIV-1 Vif interacts with ElonginBC by induced-folding to recruit its Cul5-containing ubiquitin ligase complex.
Bergeron JR; Huthoff H; Veselkov DA; Beavil RL; Simpson PJ; Matthews SJ; Malim MH; Sanderson MR
PLoS Pathog; 2010 Jun; 6(6):e1000925. PubMed ID: 20532212
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitination of APOBEC3G by an HIV-1 Vif-Cullin5-Elongin B-Elongin C complex is essential for Vif function.
Kobayashi M; Takaori-Kondo A; Miyauchi Y; Iwai K; Uchiyama T
J Biol Chem; 2005 May; 280(19):18573-8. PubMed ID: 15781449
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the interaction of full-length HIV-1 Vif protein with its key regulator CBFβ and CRL5 E3 ubiquitin ligase components.
Zhou X; Evans SL; Han X; Liu Y; Yu XF
PLoS One; 2012; 7(3):e33495. PubMed ID: 22479405
[TBL] [Abstract][Full Text] [Related]
6. Evolutionarily conserved requirement for core binding factor beta in the assembly of the human immunodeficiency virus/simian immunodeficiency virus Vif-cullin 5-RING E3 ubiquitin ligase.
Han X; Liang W; Hua D; Zhou X; Du J; Evans SL; Gao Q; Wang H; Viqueira R; Wei W; Zhang W; Yu XF
J Virol; 2014 Mar; 88(6):3320-8. PubMed ID: 24390335
[TBL] [Abstract][Full Text] [Related]
7. Core binding factor beta plays a critical role by facilitating the assembly of the Vif-cullin 5 E3 ubiquitin ligase.
Fribourgh JL; Nguyen HC; Wolfe LS; Dewitt DC; Zhang W; Yu XF; Rhoades E; Xiong Y
J Virol; 2014 Mar; 88(6):3309-19. PubMed ID: 24390320
[TBL] [Abstract][Full Text] [Related]
8. Conformational Dynamics of the HIV-Vif Protein Complex.
Ball KA; Chan LM; Stanley DJ; Tierney E; Thapa S; Ta HM; Burton L; Binning JM; Jacobson MP; Gross JD
Biophys J; 2019 Apr; 116(8):1432-1445. PubMed ID: 30961890
[TBL] [Abstract][Full Text] [Related]
9. On the solution conformation and dynamics of the HIV-1 viral infectivity factor.
Marcsisin SR; Narute PS; Emert-Sedlak LA; Kloczewiak M; Smithgall TE; Engen JR
J Mol Biol; 2011 Jul; 410(5):1008-22. PubMed ID: 21763503
[TBL] [Abstract][Full Text] [Related]
10. Dissection of the HIV Vif interaction with human E3 ubiquitin ligase.
Wolfe LS; Stanley BJ; Liu C; Eliason WK; Xiong Y
J Virol; 2010 Jul; 84(14):7135-9. PubMed ID: 20463065
[TBL] [Abstract][Full Text] [Related]
11. Identification of a Conserved Interface of Human Immunodeficiency Virus Type 1 and Feline Immunodeficiency Virus Vifs with Cullin 5.
Gu Q; Zhang Z; Gertzen CGW; Häussinger D; Gohlke H; Münk C
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263270
[TBL] [Abstract][Full Text] [Related]
12. The HIV-1 Vif PPLP motif is necessary for human APOBEC3G binding and degradation.
Donahue JP; Vetter ML; Mukhtar NA; D'Aquila RT
Virology; 2008 Jul; 377(1):49-53. PubMed ID: 18499212
[TBL] [Abstract][Full Text] [Related]
13. High-speed atomic force microscopy directly visualizes conformational dynamics of the HIV Vif protein in complex with three host proteins.
Pan Y; Shlyakhtenko LS; Lyubchenko YL
J Biol Chem; 2020 Aug; 295(34):11995-12001. PubMed ID: 32587092
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for hijacking CBF-β and CUL5 E3 ligase complex by HIV-1 Vif.
Guo Y; Dong L; Qiu X; Wang Y; Zhang B; Liu H; Yu Y; Zang Y; Yang M; Huang Z
Nature; 2014 Jan; 505(7482):229-33. PubMed ID: 24402281
[TBL] [Abstract][Full Text] [Related]
15. Interactions between HIV-1 Vif and human ElonginB-ElonginC are important for CBF-β binding to Vif.
Wang X; Wang X; Zhang H; Lv M; Zuo T; Wu H; Wang J; Liu D; Wang C; Zhang J; Li X; Wu J; Yu B; Kong W; Yu X
Retrovirology; 2013 Aug; 10():94. PubMed ID: 23988114
[TBL] [Abstract][Full Text] [Related]
16. Structural insights for HIV-1 therapeutic strategies targeting Vif.
Salter JD; Morales GA; Smith HC
Trends Biochem Sci; 2014 Sep; 39(9):373-80. PubMed ID: 25124760
[TBL] [Abstract][Full Text] [Related]
17. Identification of a critical T(Q/D/E)x5ADx2(I/L) motif from primate lentivirus Vif proteins that regulate APOBEC3G and APOBEC3F neutralizing activity.
Dang Y; Wang X; York IA; Zheng YH
J Virol; 2010 Sep; 84(17):8561-70. PubMed ID: 20592083
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 Promotes the Degradation of Components of the Type 1 IFN JAK/STAT Pathway and Blocks Anti-viral ISG Induction.
Gargan S; Ahmed S; Mahony R; Bannan C; Napoletano S; O'Farrelly C; Borrow P; Bergin C; Stevenson NJ
EBioMedicine; 2018 Apr; 30():203-216. PubMed ID: 29580840
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitination of APOBEC3 proteins by the Vif-Cullin5-ElonginB-ElonginC complex.
Shirakawa K; Takaori-Kondo A; Kobayashi M; Tomonaga M; Izumi T; Fukunaga K; Sasada A; Abudu A; Miyauchi Y; Akari H; Iwai K; Uchiyama T
Virology; 2006 Jan; 344(2):263-6. PubMed ID: 16303161
[TBL] [Abstract][Full Text] [Related]
20. Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.
He Z; Zhang W; Chen G; Xu R; Yu XF
J Mol Biol; 2008 Sep; 381(4):1000-11. PubMed ID: 18619467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]